NPI: 1417100447 · PORTLAND, ME 04101 · Community/Retail Pharmacy · NPI assigned 11/04/2008
Authorized official AYCOCK, BRANDON controls 13+ related entities in our dataset. Read more
| Authorized Official | AYCOCK, BRANDON (PRESIDENT) |
| NPI Enumeration Date | 11/04/2008 |
Other providers sharing the same authorized official: AYCOCK, BRANDON
| Provider | City | State | Total Paid |
|---|---|---|---|
| PROCARE PHARMACY DIRECT, LLC. | MONROEVILLE | PA | $227.31M |
| PROCARE PHARMACY, L.L.C. | HONOLULU | HI | $41.83M |
| CAREMARK, L.L.C. | MT PROSPECT | IL | $34.08M |
| CAREMARK, L.L.C. | REDLANDS | CA | $19.87M |
| CAREMARK, L.L.C. | TAMPA | FL | $7.28M |
| CAREMARK, L.L.C. | FAIRFIELD | NJ | $3.43M |
| CAREMARK L.L.C. | RALEIGH | NC | $2.69M |
| CAREMARK L.L.C. | LENEXA | KS | $2.54M |
| CAREMARK, L.L.C. | MILFORD | MA | $2.20M |
| CAREMARK, L.L.C. | BARTLETT | TN | $1.96M |
| PROCARE PHARMACY, LLC. | BIRMINGHAM | AL | $623K |
| PROCARE PHARMACY LLC | BOSTON | MA | $724.47 |
| CAREMARK, LLC | MT. PROSPEC | IL | $76.40 |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,008 | $26K |
| 2019 | 3,975 | $20K |
| 2020 | 3,937 | $22K |
| 2021 | 2,883 | $17K |
| 2022 | 2,218 | $12K |
| 2023 | 1,719 | $8K |
| 2024 | 1,215 | $4K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J7517 | Mycophenolate mofetil, oral, 250 mg | 2,488 | 2,038 | $47K |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 4,183 | 2,652 | $37K |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 3,595 | 3,013 | $13K |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | 6,744 | 2,944 | $9K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 2,928 | 2,549 | $1K |
| J7518 | Mycophenolic acid, oral, 180 mg | 17 | 12 | $1K |